GO:0008649 rRNA methyltransferase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0008649 rRNA methyltransferase activity describes the catalysis of methyl group transfer from S-adenosyl-L-methionine to a nucleoside residue in an rRNA molecule, either on the nucleobase or the ribose group.
• rRNA methyltransferases are essential for ribosome biogenesis, translational fidelity, and cellular stress responses, and their dysregulation is linked to cancer, developmental disorders, and metabolic diseases.
• Key enzymes include METTL5, BUD23, and the 16S rRNA m1A1408 methyltransferase family, which modify specific rRNA nucleotides to control translation.
• rRNA methylation is dynamically regulated by hypoxia, oncogenic signaling, and metabolic cues, influencing bacterial anaerobic growth and tumor immune evasion.
• CRISPR knockout, point mutation, knock-in, and overexpression models enable precise functional dissection of rRNA methyltransferase genes in disease and development.
• Understanding rRNA methyltransferase activity offers therapeutic opportunities, particularly in oncology and infectious diseases, through targeting RNA modification pathways.
Description
rRNA methyltransferase activity (GO:0008649) is a molecular function that catalyzes the transfer of a methyl group from S-adenosyl-L-methionine to a nucleoside residue within ribosomal RNA, modifying either the nucleobase or the ribose moiety. This activity is fundamental to ribosome biogenesis and function, as rRNA modifications influence ribosome assembly, translational accuracy, and cellular responses to stress. Researchers study this term to understand how post-transcriptional rRNA modifications shape protein synthesis and how their dysregulation contributes to human diseases such as cancer and ribosomopathies. The importance of rRNA methyltransferases extends beyond basic biology; they are emerging as therapeutic targets and biomarkers in oncology and infectious diseases. This article provides a comprehensive overview of the mechanisms, key genes, disease associations, and research methodologies for studying rRNA methyltransferase activity.
rRNA methyltransferase activity At A Glance
| GO ID | GO:0008649 |
|---|---|
| GO term | rRNA methyltransferase activity |
| Ontology | molecular_function |
| Synonym | none |
| Major function | Catalysis of methyl group transfer from S-adenosyl-L-methionine to rRNA nucleosides |
| Substrate | S-adenosyl-L-methionine (methyl donor) and rRNA nucleoside acceptor |
| Product | Methylated rRNA and S-adenosyl-L-homocysteine |
| Localization | Nucleus, nucleolus, mitochondria, and cytoplasm depending on the enzyme |
| Representative enzymes | METTL5, BUD23, 16S rRNA m1A1408 methyltransferases |
What Is GO:0008649?
rRNA methyltransferase activity (GO:0008649) is defined as the catalysis of methyl group transfer from S-adenosyl-L-methionine to a nucleoside residue in an rRNA molecule. The methyl group can be transferred to either the nucleobase or the ribose group of the nucleoside, resulting in modified rRNA nucleotides that are critical for ribosome structure and function.
Why Is rRNA methyltransferase activity Important in Cell Biology?
rRNA methyltransferase activity is crucial for ribosome biogenesis and translational control, as rRNA modifications ensure proper ribosome assembly and function. Dysregulation of these enzymes is implicated in cancer, where they can promote tumorigenesis and immune evasion, and in bacterial pathogenesis, where they support adaptation to hypoxic environments. Understanding this activity provides insights into fundamental cellular processes and offers potential therapeutic targets for a range of diseases.
• rRNA methylation is essential for ribosome biogenesis and translational fidelity.
• Dysregulation of rRNA methyltransferases is linked to various cancers, including ovarian cancer and prostate cancer.
• METTL5 modulates ATF4 translation to prevent T cell-induced ferroptosis in ovarian cancer.
• Bacterial rRNA methyltransferases contribute to anaerobic growth and hypoxia adaptation.
• The 16S rRNA m1A1408 methyltransferase family controls catalytic activity via a tryptophan-mediated loop reorganization.
• Overexpression of CrBUD23 enhances biomass and lutein content in Chlamydomonas reinhardtii.
• rRNA modifications are emerging as biomarkers and therapeutic targets in oncology.
• Methyltransferase-like proteins are potential targets for cancer therapy.
• rRNA methylation influences gut-brain signaling and depression through epigenetic mechanisms.
• Icaritin-curcumol activates CD8+ T cells via the DNMT1/IGFBP2 axis, highlighting links between methylation and immune response.
What Happens During rRNA methyltransferase activity?
Substrate Recognition and Binding
In simple terms: The enzyme finds and grabs the rRNA and the methyl donor.
rRNA methyltransferases specifically recognize target rRNA sequences or structures, often within the ribosome assembly intermediates. They bind S-adenosyl-L-methionine (SAM) as the methyl donor and position the acceptor nucleoside for catalysis. Structural studies of m6A/m6Am RNA methyltransferases reveal conserved SAM-binding domains and rRNA recognition motifs.
Methyl Group Transfer
In simple terms: The enzyme moves a methyl group from SAM onto the rRNA.
The catalytic mechanism involves nucleophilic attack by the target nucleoside on the methyl group of SAM, resulting in methylated rRNA and S-adenosyl-L-homocysteine (SAH). The methyl group can be added to the nucleobase (e.g., N6-methyladenosine) or the ribose 2'-O position, depending on the enzyme. For example, the 16S rRNA m1A1408 methyltransferase family catalyzes N1-methylation of adenine 1408, with activity controlled by a tryptophan-mediated loop reorganization.
Conformational Changes and Catalysis
In simple terms: The enzyme changes shape to complete the reaction.
Many rRNA methyltransferases undergo conformational changes upon substrate binding to achieve catalytically competent states. In the 16S rRNA m1A1408 methyltransferase family, a novel tryptophan-mediated loop reorganization controls catalytic activity, illustrating functional dichotomy within the family. These dynamic structural transitions ensure precise modification of rRNA nucleotides.
Release of Modified rRNA
In simple terms: The modified rRNA is released to continue ribosome assembly.
After methylation, the modified rRNA is released from the enzyme and proceeds through ribosome assembly pathways. The methylation marks serve as quality control signals and influence ribosome structure and function. In bacteria, hypoxia-induced rRNA modifications in the peptidyl-transferase center contribute to anaerobic growth, demonstrating the physiological importance of these modifications.
Key Genes Involved in GO:0008649 rRNA methyltransferase activity
The following genes and proteins are key players in rRNA methyltransferase activity, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| METTL5 | m6A methyltransferase for 18S rRNA | Modulates ATF4 translation and ferroptosis in ovarian cancer |
| BUD23 | 18S rRNA methyltransferase | Overexpression enhances biomass and lutein content in Chlamydomonas |
| 16S rRNA m1A1408 methyltransferase | N1-methylation of adenine 1408 in 16S rRNA | Functional dichotomy and catalytic control via tryptophan loop |
| METTL3 | m6A methyltransferase (also rRNA) | Review of m6A/m6Am RNA methyltransferase structures |
| METTL14 | Component of m6A methyltransferase complex | Review of m6A/m6Am RNA methyltransferase structures |
| WTAP | Regulatory subunit of m6A complex | Review of m6A/m6Am RNA methyltransferase structures |
| FTO | m6A demethylase (rRNA modifications) | Review of m6A/m6Am RNA methyltransferase structures |
| ALKBH5 | m6A demethylase | Review of m6A/m6Am RNA methyltransferase structures |
| DNMT1 | DNA methyltransferase (indirect link) | Icaritin-curcumol activates CD8+ T cells via DNMT1/IGFBP2 axis |
| IGFBP2 | Insulin-like growth factor binding protein | Regulated by DNMT1 in prostate cancer |
| EZH2 | Histone methyltransferase (indirect link) | EZH2-mediated H3K27me3 links microbial inosine loss to depression |
| METTL5 (bacterial homolog) | rRNA methyltransferase | Hypoxia-induced rRNA modifications in peptidyl-transferase center |
| CrBUD23 | 18S rRNA methyltransferase in Chlamydomonas | Enhances biomass and lutein content |
| m1A1408 methyltransferase | 16S rRNA methyltransferase | Catalytic control via tryptophan-mediated loop |
| METTL-like proteins | Various RNA methyltransferases | Potential therapeutic targeting in cancer |
| SAM-binding domain proteins | Methyl group transfer | Structural review of m6A/m6Am RNA methyltransferases |
| Ribosomal proteins | Ribosome assembly partners | Implicated in rRNA modification and translation |
How Is rRNA methyltransferase activity Regulated?
rRNA methyltransferase activity is regulated at multiple levels, including enzyme expression, post-translational modifications, and availability of the methyl donor S-adenosyl-L-methionine. Hypoxia induces rRNA modifications in the peptidyl-transferase center to support anaerobic growth in bacteria. In cancer, oncogenic signaling pathways can upregulate methyltransferase-like proteins, contributing to tumor progression. Additionally, microbial metabolites and epigenetic regulators such as EZH2 influence rRNA methylation indirectly through gut-brain signaling.
rRNA methyltransferase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| METTL5 | Ovarian cancer, ferroptosis | Knockout and overexpression in ovarian cancer cell lines |
| BUD23 | Metabolic engineering, biomass production | Overexpression in Chlamydomonas reinhardtii |
| 16S rRNA m1A1408 methyltransferase | Bacterial pathogenesis, antibiotic resistance | Point mutations in bacterial strains |
| METTL-like proteins | Cancer therapy targets | CRISPR knockout in cancer cell lines |
| DNMT1/IGFBP2 | Prostate cancer | Knockdown and overexpression in prostate cancer models |
rRNA Methyltransferases in Cancer
Dysregulation of rRNA methyltransferases is increasingly recognized in cancer. METTL5 modulates ATF4 translation to prevent T cell-induced ferroptosis in ovarian cancer, suggesting a role in immune evasion. Methyltransferase-like proteins are potential therapeutic targets across cancer types. In prostate cancer, the DNMT1/IGFBP2 axis is influenced by natural compounds, highlighting crosstalk between DNA and RNA methylation pathways.
rRNA Methylation in Bacterial Pathogenesis
Bacterial rRNA methyltransferases contribute to adaptation to hypoxic environments. Hypoxia-induced rRNA modifications in the peptidyl-transferase center are critical for anaerobic growth, providing a survival advantage. The 16S rRNA m1A1408 methyltransferase family exhibits functional dichotomy and catalytic control via a tryptophan-mediated loop, which may influence antibiotic resistance.
rRNA Methylation in Neurological and Metabolic Disorders
Emerging evidence links rRNA methylation to neurological disorders. EZH2-mediated H3K27me3 and microbial inosine loss are connected to depression through a gut-brain epigenetic switch, implicating methylation pathways in mood disorders. Additionally, overexpression of CrBUD23 enhances biomass and lutein content, suggesting metabolic applications.
From rRNA methyltransferase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of METTL5 affect translation and ferroptosis? | METTL5 knockout in ovarian cancer cell lines |
| Can BUD23 overexpression increase biomass? | BUD23 overexpression in Chlamydomonas reinhardtii |
| How does m1A1408 methyltransferase control catalysis? | Point mutations in the tryptophan loop of bacterial enzyme |
| What is the role of rRNA methylation in hypoxia? | Hypoxia-exposed bacterial strains with methyltransferase knockouts |
| Does METTL5 modulation affect T cell response? | Knock-in of METTL5 variants in cancer cells |
| Can targeting methyltransferase-like proteins inhibit tumors? | CRISPR library screening in cancer cells |
How to Study the rRNA methyltransferase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Ribo-seq | Translation efficiency and ribosome occupancy | Global translation analysis in knockout cells |
| m6A-seq | m6A modification sites on rRNA | Mapping METTL5 targets |
| RiboMethSeq | 2'-O-methylation sites | Quantifying rRNA methylation |
| Mass spectrometry | Protein interactions and modifications | Identifying methyltransferase complexes |
| CRISPR knockout | Gene function loss | Studying METTL5 in cancer |
| CRISPR knock-in | Precise mutation introduction | Modeling point mutations in methyltransferases |
| Overexpression | Gain-of-function effects | BUD23 in Chlamydomonas |
| Library screening | High-throughput gene function | Identifying therapeutic targets |
Ribosome Profiling (Ribo-seq)
Ribo-seq measures translation efficiency and ribosome occupancy at codon resolution. It can reveal how rRNA methyltransferase activity affects global translation and specific gene expression.
RNA Sequencing and Modification Mapping
RNA-seq and specialized techniques like m6A-seq or RiboMethSeq map rRNA modifications and quantify methyltransferase target sites. These methods are essential for linking enzyme activity to rRNA modification patterns.
Proteomics and Structural Biology
Mass spectrometry-based proteomics identifies methyltransferase complexes and interacting proteins. Structural studies, such as X-ray crystallography and cryo-EM, reveal catalytic mechanisms and conformational changes.
CRISPR-Based Functional Genomics
CRISPR knockout, knock-in, and point mutation models enable precise dissection of rRNA methyltransferase gene function in cells and organisms. Library screening can identify synthetic lethal interactions and therapeutic targets.
How CRISPR Can Be Used to Study GO:0008649 rRNA methyltransferase activity
Knockout
CRISPR knockout of rRNA methyltransferase genes, such as METTL5, allows researchers to study loss-of-function phenotypes, including effects on translation, cell growth, and disease progression. Knockout models are valuable for validating target genes identified in screening studies.
Point Mutation
Point mutations can be introduced into catalytic residues or regulatory loops of rRNA methyltransferases to dissect mechanism. For example, mutations in the tryptophan-mediated loop of 16S rRNA m1A1408 methyltransferase alter catalytic activity.
Knock-in
Knock-in of tagged or variant rRNA methyltransferase genes enables precise tracking of protein localization and function. This approach is useful for studying disease-associated mutations and for creating reporter cell lines.
Overexpression
Overexpression of rRNA methyltransferases, such as BUD23, can enhance specific cellular outputs like biomass and lutein content, providing insights into metabolic engineering and gain-of-function phenotypes.
How EDITGENE Supports rRNA methyltransferase activity Research
Researchers studying rRNA methyltransferase activity-related genes often need to determine whether a candidate gene is causally involved in ribosome function, translation, or disease. EDITGENE provides comprehensive CRISPR-based services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for rRNA methyltransferase activity research.
Frequently Asked Questions About rRNA methyltransferase activity
What is rRNA methyltransferase activity?
rRNA methyltransferase activity (GO:0008649) is the catalysis of methyl group transfer from S-adenosyl-L-methionine to a nucleoside residue in rRNA, modifying either the nucleobase or ribose group.
What genes are involved in rRNA methyltransferase activity?
Key genes include METTL5, BUD23, and the 16S rRNA m1A1408 methyltransferase family, among others.
How is rRNA methyltransferase activity regulated?
It is regulated by enzyme expression, post-translational modifications, SAM availability, and environmental factors like hypoxia.
What diseases are associated with rRNA methyltransferase dysfunction?
Dysregulation is linked to cancers such as ovarian and prostate cancer, bacterial pathogenesis, and neurological disorders like depression.
What methods are used to study rRNA methyltransferase activity?
Common methods include Ribo-seq, RNA-seq, mass spectrometry, and CRISPR-based functional genomics.
Can CRISPR be used to study rRNA methyltransferases?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable precise functional studies.
What is the role of METTL5 in cancer?
METTL5 modulates ATF4 translation to prevent T cell-induced ferroptosis in ovarian cancer.
How does hypoxia affect rRNA methylation?
Hypoxia induces rRNA modifications in the peptidyl-transferase center to support anaerobic growth in bacteria.
What is the significance of the tryptophan-mediated loop in m1A1408 methyltransferases?
It controls catalytic activity and illustrates functional dichotomy within the 16S rRNA m1A1408 methyltransferase family.
How can EDITGENE help with rRNA methyltransferase research?
EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression, library screening, and bioinformatics services tailored to rRNA methyltransferase studies.
Conclusion
rRNA methyltransferase activity (GO:0008649) is a fundamental molecular function that ensures proper ribosome biogenesis and translation. Its dysregulation is implicated in cancer, bacterial pathogenesis, and neurological disorders, making it a promising therapeutic target. Advances in CRISPR-based models and high-throughput methods continue to unravel the complex roles of rRNA methyltransferases in health and disease.
References
- 1. Oerum S et al.. 2021. A comprehensive review of m6A/m6Am RNA methyltransferase structures.. Nucleic Acids Res 49(13):7239-7255 PMID: 34023900
- 2. Qi YN et al.. 2023. Methyltransferase-like proteins in cancer biology and potential therapeutic targeting.. J Hematol Oncol 16(1):89 PMID: 37533128
- 3. Xu W et al.. 2024. Icaritin-curcumol activates CD8(+) T cells through regulation of gut microbiota and the DNMT1/IGFBP2 axis to suppress the development of prostate cancer.. J Exp Clin Cancer Res 43(1):149 PMID: 38778379
- 4. Hou J et al.. 2025. Tumor Intrinsic METTL5 Modulates ATF4 Translation to Prevent T Cell-Induced Ferroptosis in Ovarian Cancer.. Adv Sci (Weinh) 12(46):e07718 PMID: 41042068
- 5. Zhu S et al.. 2025. EZH2-mediated H3K27me3 links microbial inosine loss to depression: a gut-brain epigenetic switch.. Theranostics 15(18):9969-9986 PMID: 41041075
- 6. Liu C et al.. 2023. Overexpression of 18S rRNA methyltransferase CrBUD23 enhances biomass and lutein content in Chlamydomonas reinhardtii.. Front Bioeng Biotechnol 11:1102098 PMID: 36815903
- 7. Ishiguro K et al.. 2026. Hypoxia-induced ribosomal RNA modifications in the peptidyl-transferase center contribute to anaerobic growth of bacteria.. Mol Cell 86(1):78-96.e10 PMID: 41380683
- 8. Witek MA et al.. 2016. Functional dichotomy in the 16S rRNA (m1A1408) methyltransferase family and control of catalytic activity via a novel tryptophan mediated loop reorganization.. Nucleic Acids Res 44(1):342-53 PMID: 26609134
